A detailed history of Man Group PLC transactions in Chimerix Inc stock. As of the latest transaction made, Man Group PLC holds 13,216 shares of CMRX stock, worth $12,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,216
Previous 13,216 -0.0%
Holding current value
$12,158
Previous $14,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.91 - $1.26 $28,195 - $39,039
-30,984 Reduced 70.1%
13,216 $14,000
Q2 2023

Aug 14, 2023

SELL
$1.1 - $1.54 $112,823 - $157,953
-102,567 Reduced 69.88%
44,200 $53,000
Q1 2023

May 15, 2023

BUY
$1.19 - $2.09 $13,530 - $23,763
11,370 Added 8.4%
146,767 $184,000
Q4 2022

Feb 14, 2023

BUY
$1.67 - $2.35 $207,575 - $292,097
124,297 Added 1119.79%
135,397 $251,000
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.76 $577,699 - $880,911
-319,171 Reduced 96.64%
11,100 $21,000
Q2 2022

Aug 15, 2022

BUY
$1.34 - $5.34 $442,563 - $1.76 Million
330,271 New
330,271 $687,000
Q3 2021

Nov 15, 2021

SELL
$5.94 - $8.75 $353,863 - $521,263
-59,573 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$7.54 - $9.79 $146,095 - $189,691
19,376 Added 48.2%
59,573 $477,000
Q1 2021

May 17, 2021

SELL
$4.76 - $11.25 $1.49 Million - $3.53 Million
-313,551 Reduced 88.64%
40,197 $387,000
Q4 2020

Feb 16, 2021

SELL
$2.43 - $5.42 $59,134 - $131,895
-24,335 Reduced 6.44%
353,748 $1.71 Million
Q3 2020

Nov 16, 2020

SELL
$2.3 - $3.72 $8,740 - $14,136
-3,800 Reduced 1.0%
378,083 $941,000
Q2 2020

Aug 14, 2020

SELL
$1.33 - $3.63 $37,905 - $103,455
-28,500 Reduced 6.94%
381,883 $1.18 Million
Q1 2020

May 15, 2020

SELL
$1.27 - $2.33 $56,007 - $102,753
-44,100 Reduced 9.7%
410,383 $591,000
Q4 2019

Feb 18, 2020

SELL
$1.3 - $2.72 $14,040 - $29,376
-10,800 Reduced 2.32%
454,483 $923,000
Q3 2019

Nov 14, 2019

SELL
$1.93 - $4.21 $687,940 - $1.5 Million
-356,446 Reduced 43.38%
465,283 $1.09 Million
Q2 2019

Aug 14, 2019

SELL
$2.05 - $4.32 $1,434 - $3,024
-700 Reduced 0.09%
821,729 $3.55 Million
Q1 2019

May 15, 2019

SELL
$1.79 - $3.12 $10,034 - $17,490
-5,606 Reduced 0.68%
822,429 $1.73 Million
Q4 2018

Feb 14, 2019

SELL
$2.24 - $3.9 $193,536 - $336,960
-86,400 Reduced 9.45%
828,035 $2.13 Million
Q3 2018

Nov 14, 2018

SELL
$3.58 - $4.9 $75,928 - $103,924
-21,209 Reduced 2.27%
914,435 $3.56 Million
Q2 2018

Aug 14, 2018

SELL
$4.43 - $5.14 $415,494 - $482,085
-93,791 Reduced 9.11%
935,644 $4.45 Million
Q1 2018

May 15, 2018

BUY
$4.65 - $5.9 $4.79 Million - $6.07 Million
1,029,435 New
1,029,435 $5.35 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $80.6M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.